We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+7.98%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$480M
AUM Growth
+$96.7M
(+25%)
Cap. Flow
+$82.2M
Cap. Flow
% of AUM
17.13%
Top 10 Holdings %
Top 10 Hldgs %
19.96%
Holding
645
New
258
Increased
78
Reduced
78
Closed
231
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$45.7M |
| 2 |
Nasdaq
NDAQ
|
+$5.95M |
| 3 |
Fidelity National Information Services
FIS
|
+$5.66M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$5.09M |
| 5 |
Novartis
NVS
|
+$5.01M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$5.84M |
| 2 |
ExxonMobil
XOM
|
+$5M |
| 3 |
CrowdStrike
CRWD
|
+$4.96M |
| 4 |
British American Tobacco
BTI
|
+$4.57M |
| 5 |
Blackstone
BX
|
+$4.42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.69% |
| 2 | Consumer Discretionary | 15.64% |
| 3 | Healthcare | 14.23% |
| 4 | Financials | 8.55% |
| 5 | Communication Services | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Rocket Companies
RKT
$39.2B
| $191K | 0.04% |
+21,072
| New | +$182K |
|
|
RCM
402
DELISTED
R1 RCM Inc. Common Stock
RCM
| $185K | 0.04% |
+12,347
| New | +$169K |
|
403
ASE Group
ASX
$80.9B
| $174K | 0.04% |
+21,851
| New | +$160K |
|
|
ERF
404
DELISTED
Enerplus Corporation
ERF
| $174K | 0.04% |
+12,055
| New | +$194K |
|
405
Blue Owl Capital
OWL
$7.81B
| $172K | 0.04% |
+15,539
| New | +$186K |
|
406
United Microelectronic
UMC
$48.4B
| $163K | 0.03% |
18,637
+52
| +0.3% | +$421 |
|
407
Telephone and Data Systems
TDS
$4.03B
| $136K | 0.03% |
12,903
-20,571
| -61% | -$240K |
|
408
Under Armour
UAA
$2.88B
| $134K | 0.03% |
14,095
-18,823
| -57% | -$196K |
|
409
Credo Technology Group
CRDO
$41.9B
| $129K | 0.03% |
+13,737
| New | +$173K |
|
|
FOLD
410
DELISTED
Amicus Therapeutics
FOLD
| $116K | 0.02% |
+10,419
| New | +$128K |
|
411
Cemex
CX
$16.7B
| $115K | 0.02% |
+20,854
| New | +$106K |
|
|
INFN
412
DELISTED
Infinera Corporation Common Stock
INFN
| $88.2K | 0.02% |
+11,361
| New | +$82.6K |
|
413
First Majestic Silver
AG
$8.68B
| $85.3K | 0.02% |
+11,834
| New | +$87.2K |
|
414
ADT
ADT
$5.63B
| $80.7K | 0.02% |
+11,156
| New | +$91K |
|
415
Alcoa
AA
$12.6B
| – | – |
-24,720
| Closed | -$1.12M |
|
416
Arch Capital
ACGL
$33.8B
| – | – |
-9,609
| Closed | -$603K |
|
417
Acadia Healthcare
ACHC
$3B
| – | – |
-6,200
| Closed | -$510K |
|
418
Archer Daniels Midland
ADM
$37.4B
| – | – |
-2,958
| Closed | -$275K |
|
419
American Electric Power
AEP
$68.8B
| – | – |
-2,194
| Closed | -$208K |
|
420
Aflac
AFL
$63.9B
| – | – |
-6,992
| Closed | -$503K |
|
421
Alamos Gold
AGI
$13.1B
| – | – |
-15,749
| Closed | -$159K |
|
422
American International
AIG
$42.5B
| – | – |
-21,389
| Closed | -$1.35M |
|
423
AMC Entertainment Holdings
AMC
$2.38B
| – | – |
-12,331
| Closed | -$502K |
|
424
America Movil
AMX
$72.1B
| – | – |
-11,192
| Closed | -$204K |
|
425
Arista Networks
ANET
$248B
| – | – |
-14,484
| Closed | -$439K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q1 2023 Portfolio in Review
As of Q1 2023, Seven Eight Capital held 645 positions worth $480M, up 25% from $383M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Seven Eight Capital deployed $82.2M of net new capital in Q1 2023, opening 258 new positions and adding to 78 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 114,438 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Advanced Micro Devices, an estimated $5.84M trimmed.
- Seven Eight Capital's largest Q1 2023 buy was State Street SPDR S&P 500 ETF Trust: 114,438 shares worth $46.8M.
- Seven Eight Capital added most to BioMarin Pharmaceuticals in Q1 2023, an estimated $5.09M increase.
- Seven Eight Capital's biggest Q1 2023 reduction was Advanced Micro Devices, cutting an estimated $5.84M.
- Seven Eight Capital fully exited ExxonMobil in Q1 2023, selling an estimated $5M.
- Seven Eight Capital's ten largest holdings make up 20% of its $480M portfolio in Q1 2023.
- Seven Eight Capital opened 258 new positions and closed 231 in Q1 2023.
- Seven Eight Capital's portfolio value rose 25% quarter-over-quarter to $480M.
Based on Seven Eight Capital's 13F filing for Q1 2023, filed 15 May 2023.